EBS — Emergent BioSolutions Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 13
- all time
- Members · 12m
- 0
- 0 buys · 0 sells · by trade date
- Latest filing
- 01-10
- 2025-01-10
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 0
- every row filed inside 45 days
- 13F holders
- —
- issuer resolved · no holder rows
Congress · disclosure timeline
By trade date · 24 months · 1 row ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.1 dated disclosure in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M.
Members active in EBS
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).No member disclosed EBS in the trailing 12 months.
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2025-01-10 | Steve Cohen D–TN-9 | SELL | Traded 2024-12-11 +30d | $1K–$15K | ||
| 2021-12-13 | Josh Gottheimer D–NJ-5 | SELL JT (jointly owned) | Traded 11-05 +38d | $1K–$15K | ||
| 2021-11-15 | Josh Gottheimer D–NJ-5 | BUY JT (jointly owned) | Traded 10-18 +28d | $1K–$15K | ||
| 2021-10-13 | Josh Gottheimer D–NJ-5 | SELL partial · JT (partial sale, jointly owned) | Traded 09-15 +28d | $1K–$15K | ||
| 2021-03-10 | Josh Gottheimer D–NJ-5 | SELL partial · JT (partial sale, jointly owned) | Traded 02-23 +15d | $1K–$15K | ||
| 2020-12-15 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 11-24 +21d | $1K–$15K | ||
| 2020-08-19 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 07-30 +20d | $1K–$15K | ||
| 2020-07-17 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 06-30 +17d | $1K–$15K | ||
| 2020-07-17 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 06-19 +28d | $1K–$15K | ||
| 2020-07-09 | Josh Gottheimer D–NJ-5 | BUY JT (jointly owned) | Traded 06-26 +13d | $1K–$15K |
Institutional holders · 13F
Mapped, but not in the published aggregate.
EBS resolves to Emergent BioSolutions Inc. (CIK 1367644), but this build's aggregate holds no entity-keyed top-holder rows for it. EBS on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to Emergent BioSolutions Inc. (CIK 1367644), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Congress ↔ notable managers · EBS
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers
Not available for EBS: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗
No moves on either side in the window.